Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441775 · ClinicalTrials.gov registry record
Artificial Intelligence for Prostate Cancer Treatment Planning
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 5
- Enrollment target
NCT04441775 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT04441775 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This project's goal is to develop and test an application that uses Artificial Intelligence (AI) to improve consistency and quality of Radiation Treatment (RT) plans for prostate cancer. By understanding expert planner preferences in structure contouring and treatment planning, and combining this framework with planning data and outcomes amassed in NRG clinical trials, AI models may be trained to produce contours and treatment plans that are indistinguishable or even potentially deemed superior to those produced by individual experts. At the conclusion of this contract, the awardees will provide a software product which, when given the input of a description of desired anatomical target volumes and target doses along with a patient's CT scans, will generate target volumes and radiation treatment plans based upon a "gold standard" amalgamated from the input of multiple experts, thereby achieving desired doses to target volumes while meeting or exceeding the dose-volume constraints imposed by adjacent normal tissues.
Interventions
- OTHER AI-assisted RT modelling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2022-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04441775
The ClinicalTrials.gov registry entry for NCT04441775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AI-assisted RT modelling is the first listed.
NCT04441775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04441775 about?
NCT04441775 is a clinical study titled "Artificial Intelligence for Prostate Cancer Treatment Planning". This project's goal is to develop and test an application that uses Artificial Intelligence (AI) to improve consistency and quality of Radiation Treatment (RT) plans for prostate cancer. By understanding expert planner preferences in structure contouring and treatment planning, and combining this fr...
What is the current status of trial NCT04441775?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2020-06-22. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT04441775?
The interventions under investigation include: AI-assisted RT modelling (OTHER).
Who is sponsoring clinical trial NCT04441775?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.